Alpine Immune Sciences's market cap is currently ―. The company's EPS TTM is $-0.692; its P/E ratio is -93.27; Alpine Immune Sciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 30.85M	$ 10.04M	$ 8.59M	$ 9.39M	$ 2.78M
Gross Profit	$ 30.85M	$ 10.04M	$ 8.59M	$ 9.39M	$ 2.78M
EBIT	$ 5.86M	$ -11.72M	$ -13.13M	$ -13.20M	$ -17.11M
EBITDA	$ 11.82M	$ -13.67M	$ -14.64M	$ -14.75M	$ -18.26M
Net Income Common Stockholders	$ 5.96M	$ -11.72M	$ -13.16M	$ -13.27M	$ -18.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 327.41M	$ 193.45M	$ 203.80M	$ 194.93M	$ 237.64M
Total Assets	$ 379.85M	$ 240.55M	$ 252.84M	$ 260.41M	$ 286.69M
Total Debt	$ 9.91M	$ 10.16M	$ 10.39M	$ 12.83M	$ 14.22M
Net Debt	$ -317.50M	$ -183.30M	$ -193.41M	$ -182.10M	$ -223.42M
Total Liabilities	$ 51.91M	$ 78.92M	$ 83.45M	$ 92.56M	$ 107.27M
Stockholders Equity	$ 327.94M	$ 161.63M	$ 169.39M	$ 169.54M	$ 179.42M
Cash Flow	-
Free Cash Flow	$ -19.09M	$ -15.80M	$ -18.37M	$ -26.25M	$ -16.90M
Operating Cash Flow	$ -18.97M	$ -15.80M	$ -18.09M	$ -26.15M	$ -16.79M
Investing Cash Flow	$ -112.70M	$ -535.00K	$ 29.33M	$ 28.35M	$ -107.90M
Financing Cash Flow	$ 156.61M	$ 1.20M	$ 8.40M	$ -1.09M	$ 11.54M

Currency in USD

Alpine Immune Sciences Earnings and Revenue History

Income Statement >

Alpine Immune Sciences Debt to Assets

Balance Sheet >

Alpine Immune Sciences Cash Flow

Cash Flow >

Alpine Immune Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing